1. Field of the Invention
The present inventions relate generally to modular bilumenal endograft systems for the treatment of abdominal aortic aneurysms. Specifically, the present invention includes systems for endovascular repair with percutaneously emplaced grafts disposed at optimized orientations in a primary stent assembly, or aortic cuff having a shotgun neck framework, inter alia.
2. Description of the Related Art
The aorta delivers blood and oxygen to all arterial branches of the body, and as such is the largest artery of the human body. The normal diameter of the thoracic aorta is in the order of about 3 cm at the tubular ascending portion, 2.5 cm at the descending thoracic aorta and 2 cm in the infrarenal abdominal aorta. The aortic dimensions vary relative to body surface area, age and gender with males typically having larger aortic dimensions than females.
An enlargement of the aorta beyond its normal diameter is termed an aneurysm and is generally a result of deterioration and weakness of the arterial wall. In the United States approximately 15,000 individuals a year die as a result of aneurysm rupture. If the aneurysm is diagnosed prior to rupture it can be repaired
The gold standard for aneurysm repair has long been surgical repair. This typically involves cutting open the dilated portion of the aorta and inserting a synthetic (Dacron or Gore-tex) tube. Once the tube is sewn into the proximal and distal portions of the aorta, the aneurysmal sac is wrapped around the artificial tube and sutured closed. Although effective surgical repair usually involves a 7-10 day post surgical hospital stay and several months of recovery.
In recent years, the endolumenal treatment of abdominal aortic aneurysms has emerged as a minimally invasive alternative to open surgery repair. In endovascular surgery, a synthetic graft (stent-graft consisting of a polyester or Teflon® tube inside a metal frame) is packaged within a catheter and the device is inserted, via a surgical cutdown, into the bloodstream through an artery in the leg. The catheter is guided to the desired location by the surgeon via X-ray visualization. Once in place, the graft is released from the catheter and expanded within the aneurysm sac. The stent-graft reinforces the weakened section of the aorta to prevent rupture of the aneurysm. The metal frame expands like a spring and holds the graft tightly against the wall of the aorta, cutting off the blood supply to the aneurysm. The blood now flows through the stent-graft and isolates the aneurysm. Endolumenal aneurysm treatment is generally more benign, resulting in a 1-2 day hospital stay and 1-2 week recovery.
During the past decade, numerous medical device companies have introduced endografts for the treatment of abdominal aortic aneurysms to the market. These include devices by Medtronic®, Gore®, Cook®, Endologix®, Cordis® and others. These devices are fabricated from surgical grade materials which are inherently thick and rigid by nature. Although clinically effective, the bulky construct of these devices require they be delivered through catheters 20 Fr or larger in diameter and require a surgical cutdown on the artery to be introduced. Although the cut-down approach significantly reduces patient recovery time and the acute complications that often accompany open surgical intervention, the ultimate goal and the market trend is to reduce the endograft and delivery system profile to enable the endograft to be delivered percutaneously thus eliminating the need for the cut-down procedure.
Briefly stated, systems methods and devices address and ameliorate intralumenal aneurysms by excluding the same through endograft by-pass techniques. Percutaneuous emplacement, use of improved aortic-stent assemblies and shotgun neck framing facilitates placement of modular graft sections, for example, to treat abdominal aortic aneurysms.
According to embodiments there are disclosed bifurcated endografts for aneurysm treatment which comprise, in combination, systems that can be percutaneously delivered through a 12 Fr or smaller vascular introducer, further comprising at least an endograft element disposed within a primary stent assembly, or aortic cuff, which is tubular. Those skilled in the art readily understand the interchangeability of “primary stent assembly” with both aortic and tubular cuff and/or trunk, as coextensively defined throughout the instant specification.
According to embodiments, there is disclosed a modular two-piece abdominal aortic endograft system with “D-shaped” proximal ends and circular distal ends which can be axially aligned within the aorta; wherein each said modular piece is independently adjustable up and down relative to each other to accommodate the naturally anatomically variable orientation of the renal arteries.
According to embodiments, there is disclosed a method of constructing a modular quasi-customizable endovascular graft in situ, comprising in combination the steps of translumenally advancing a first deployment catheter to access the aorta deploying a tubular cuff within the aorta translumenally advancing a second deployment catheter to access the tubular cuff from the bottom deploying a first iliac graft within in the tubular cuff translumenally advancing a third deployment catheter to access the tubular cuff from the bottom and deploying a second iliac graft within the tubular cuff.
According to embodiments, there is disclosed a low-profile modular endograft system for comprising, in combination: a cuff and at least two endograft units, each endograft unit having a lumen, a proximal end and a distal end, wherein each endograft unit comprises a flexible tubular woven wire frame having a proximal end with a generally D-shaped cross-section configured to be secured at the cuff and a distal end having a generally circular cross section-configured to be placed and fixed in each of the iliac arteries, and a seal between each of said endograft units and said cuff
Additional objects and features of the present invention will become more apparent and the invention will be best understood from the following Detailed Description of the Invention, when read with reference to the accompanying drawings, wherein:
The present inventors have discovered that a device engineered for percutaneous placement having an introduction profile of at least about 12 Fr solves numerous problems in the art of endovascular grafting, particularly where bifurcated (split into at least two branches) and assembled modularly. Expressly incorporated herein by reference are U.S. Pat. and Publication Nos. 5,676,697; 6,383,193; 5,316,023; 5,078,726; 5,928,279; 5,897,587; 6,001,125; 6,004,348; 6,517,571; 6,786,920; 6,981,982; 6,808,533; 6,790,225; 2009/0182413; 2009/0173439; 2009/0036973; 2008/0208325; 2008/0114449; 2004/0162604; 2004/0054397.
The embodiments of the present invention described below relate particularly to a system for use in treating or repairing aneurysms. While the description sets forth various embodiment specific details, it will be appreciated that the description is illustrative only and should not be construed in any way as limiting the invention. Furthermore, various applications of the invention, and modifications thereto, which may occur to those who are skilled in the art, are also encompassed by the general concepts described below, as detailed herein and claimed as proprietary according to the instant teachings.
Systems for repairing abdominal and thoracic aortic aneurysms come in many forms. A typical system includes an anchoring and/or sealing component which is positioned in healthy tissue above the aneurysm and one or more grafts which are in fluid communication with the anchoring and/or sealing component. Essentially, the grafts are the components of the system that are utilized to establish a fluid flow path from one section of an artery to another section of the same or different artery, thereby bypassing the diseased portion of the artery. Essentially, the endovascular grafting system of the present invention comprises a number of components that make up a modular system. Although the overall scope of embodiments each comprises a number of components, the challenges associated with these types of systems include profile, flexibility and accessibility.
Referring now to
According to the present invention, EVAR (endovascular aneurysm repair) of an abdominal aortic aneurysm with a stent graft includes features such as low introductory profiles, preferably 12 Fr or less, that expands up to 25 mm or more and can treat a short infrarenal neck, 15 mm long or less, which is constructed intralumenally from ultrathin graft materials attached to frames which provide structural support and enable the device to flex and conform to tortuous vessel anatomy.
According to embodiments, elements of a stent graft may comprise at least three layers, including a middle layer of a spiral wire or laser cut mesh of elastic or semi-rigid material (for example, metal, shape memory metal such as Nitinol®, plastic, shape memory plastic or other flexible expandable material), and an outer layer of ultrathin non-permeable expanded PTFE tape overwrap with a thickness of approximately 0.0005 inch. and a third inner layer of an ultrathin longitudinally stretchable expanded PTFE (polytetrafluoroethylene) tube of 0.004 inch or less, and/or dacron. The layers are thermally fused or bonded around the frame and serve as the building material for the stent graft composite. In embodiments, the expanded PTFE is impermeable to liquid or water. The inner PTFE layer and the outer PTFE layer serve to assure sufficient liquid-tightness of the composite constructing material to isolate the aneurysm from blood pressure. Alternatively, the graft material may also be an ultrathin tightly woven polyester fabric or like material 0.004 inch thick or less that is fastened to the frame with thread or glue at the proximal and distal ends and corrugated along the length to enable the graft to lengthen with the stent in the collapsed state and contract or shorten as the stent foreshortens during deployment.
According to embodiments, the mate-able pair of each D-graft set includes sides (as illustrated in
In another embodiment, barbs can be incorporated and spaced apart appropriately at about the proximal portion of the D-shaped graft so that the barbs (1ah) would be deployed radially outwardly to anchor the graft at the aorta in either the supra or infra renal positions or both (
According to embodiments the distal segment of each D-shaped portion 1 of the stent graft has a bare stent segment of approximately 25 mm length which is not covered by graft material
According to embodiments, for example two independent stent grafts 1 (as shown in
D-grafts 1 allow a non-custom method of supra and infra renal EVAR by separating treatment of each renal artery area. Position of the grafts can be independently adjusted up or down to the height of the renal ostia to accommodate varying anatomy. Complete EVAR can be performed with only two components selected for diameter (proximal and distal), length and renal ostia when desired.
According to embodiments, for example, D-shaped stent grafts 1 of the present invention form a cylindrical-like tubular appearance when two flat sides of the grafts are emplaced as they face each other or mate intimately against each other as in
Referring to
The central lumen 108 is optionally divided by a divider 110 into a first flow path 112 and a second flow path 114. As illustrated in cross sectional view in
The tubular body 102 may comprise a wire weave 116, utilizing any of a variety of metal or polymeric wires or filaments depending upon the desired clinical performance. In one implementation of the invention, the wire weave comprises a nickel titanium alloy having a diameter of no more than about 0.020 inches, and preferably no more than about 0.0010 inches. In one implementation of the invention, the wire has a diameter of approximately 0.009 inches and braided into a diamond shape with a diameter of approximately 0.160 inch with intersecting angles of 30 degrees. Alternatively the tubular body 102 can be laser cut from a metal tube such as Nitinol® then expanded and heat set into the desired final configuration.
In the vicinity of a central zone 118, the tubular body 102 is provided with a seal-supporting fabric layer 120 which overlaps on the outside of primary stent assembly 118, for redundant or supplemental sealing and endothelialization purposes ads described above and below and claimed hereafter. The central zone 118 is positioned between a superior zone 122 and an inferior zone 124. The overall length of the tubular body 102 may be varied considerably, depending upon the desired clinical performance and intended patient population. In general, tubular body 102 will have an axial length of at least about 40 mm and not more than about 80 mm. Typically, the axial length of tubular body 102 will be within the range of from about 45 mm to about 65 mm. The axial length of the central zone 118, and thus the axial length of the impermeable layer 120 will typically be at least about 10% and often at least about 20% of the overall length of the tubular body 102. In one embodiment, the tubular body 102 is approximately 60 mm in length, and the central zone 118 is approximately 15 mm in length.
Referring to
Referring to
The cross-sectional configuration of the graft 130 may be constant throughout its axial length. Alternatively, the cross-sectional configuration may transition into a substantially circular cross-section, such as is illustrated in
The inferior zone 124 is generally at least about 15 mm and preferably within the range of from about 5 mm to about 10 mm in length. The length of the superior zone 122 is generally at least about 25 mm and preferably within the range of from about 15 mm to about 35 mm.
The permeable/endotheliazation layer 120 may comprise any of a variety of materials described previously herein, depending upon a variety of factors such as thrombogenicity, porosity and the desired crossing profile of the deployment catheter. In one implementation of the invention, impermeable layer 120 comprises ePTFE, having a wall thickness of no more than about 0.004 inch. Dacron and any of a variety of other ultrathin materials may alternatively be utilized.
The aortic cuff/primary stent assembly 110, 111, 118 are configured to cooperate with a first and second independently deployable D-grafts or sleeves, to produce a formed in situ bifurcation graft. Alternatively the D-grafts can also be circular grafts deployed within the circular segment 120 of cuff 100.
Referring now still also to
A second iliac D-graft 130B extends axially through the second flow path 114. Second iliac graft 130B may be aligned in a mirror image fashion with respect to first iliac graft 130A. Alternatively, iliac graft 130B may be positioned higher or lower in the superior inferior axis than the first iliac graft 130A. Thus, the superior end of a first iliac graft may be positioned at least about 0.5 cm, in some assemblies at least about 1 cm, and in certain applications at least about 2 cm higher than the superior end of a second iliac graft. This customization may be utilized to accommodate dissimilar locations (levels) of the renal arteries when considered along the superior inferior axis, and increase the sealing area as described infra.
In embodiments of the invention, material 120 of aortic cuff 100 is constructed from polyester and the D-graft 130 covering is constructed from ePTFE, Dacron, or combinations of the materials.
Assembly of the modular abdominal aortic aneurysm graft in accordance with the present invention will be illustrated with reference to
A deployment catheter 160 is illustrated spanning the aneurysm 138. Deployment catheter 160 is positioned using conventional techniques which will not be described in detail herein. In general, a guidewire having an outside diameter typically within the range of from about 0.025 to about 0.035 is percutaneously inserted into the arterial system such as at the femoral artery. The guidewire is advanced superiorly through the corresponding iliac toward the aorta, and advanced to the level of the renal arteries or higher. The deployment catheter 160 is thereafter advanced over the wire into the position illustrated in
Deployment catheter 160 comprises an elongate flexible tubular body 162 having a proximal end 164. An elongate flexible support tube 166 extends axially throughout the length of the tubular body 162 which carries a nose cone or other blunt tip 168. A part line 170 separates the nose cone 168 from the tubular body 162, and one or more radiopaque markers is carried by one or more of the nose cone 168, tubular body 162 and support tube 166 to facilitate navigation under fluoroscopic guidance to the desired deployment site. Typically, the deployment catheter 160 will be percutaneously introduced and translumenally advanced to approximately the position illustrated in
As illustrated in
The aortic cuff 100 is radially compressed and constrained within the distal end 164 of the tubular body 162. Proximal axial retraction of the tubular body 162 relative to the support tube 166 gradually exposes the aortic cuff 100. Aortic cuff 100 radially outwardly expands under its inherent bias, until encountering resistance to further expansion provided by the wall of the aorta. Prior to full deployment of the aortic cuff 100 the cuff can be recaptured by catheter 164 and repositioned if necessary so that the distal end of impermeable segment 118 is positioned just below the lowest renal artery and above the aneurysm within the healthy neck of the aorta. Proximal retraction of the tubular body 162 is continued until, as illustrated in
Referring to
The tubular body 204 is thereafter proximally retracted relative to the distal nose cone 202, thereby separating the outside sidewall of the catheter at the part line 206 and exposing the ipsilateral iliac D-graft. Proximal retraction of the tubular body 204 along an axial length greater than the length of the iliac graft exposes the iliac graft and allows it to fully radially expand. If necessary, as the D segment is deployed, tubular body 204 can be advanced to recapture the stent graft for repositioning. As the D segment is deployed the catheter is rotated so that the D segment is aligned within segment 102 and within the limits set by the inside diameter of the first flow path 112 within aortic cuff 100 at the superior end and the diameter of the iliac artery at the inferior end. The ipsilateral iliac graft deployment catheter 200 may thereafter be proximally withdrawn from the patient, leaving the partially assembled construct as illustrated in
A contralateral femoral access is then provided, and a guidewire advanced via the contralateral femoral and iliac pathways and through the second flow path 114 in aortic cuff 100. A contralateral iliac graft deployment catheter 220 is thereafter translumenally advanced over the wire and into the position schematically illustrated in
Grafts constructed in accordance with the present invention are believed to enable the construction of an endovascular straight segment or bifurcation graft utilizing a catheter which can have a lower crossing profile than those conventionally found in the prior art. For example, the braided construction of the wire support allows a degree of axial elongation and radial compression which permits the compressed graft to be loaded within a smaller deployment catheter than a wire frame constructed in a conventional “Z stent” configuration. In general, bifurcation grafts in accordance with the present invention are preferably dimensioned such that they can be placed in an aorta having a diameter of at least about 25 mm, via an access catheter having a diameter of no more than about 12 Fr. In one implementation of the invention, the bifurcation graft may be implanted in an aorta having a diameter of at least about 25 mm, using a deployment catheter having a diameter of no more than about 12 French. This implementation of the invention has an aortic cuff which expands to an average outside diameter of at least about 25 mm in an unconstrained expansion.
Generally, the aortic cuff 100 delivered from a 12 French catheter will have an unconstrained expansion to a diameter of at least about 20 mm, and preferably at least about 27 mm. Primary stent assembly 111 likewise may be customized per the anatomy of the patient.
The present invention additionally permits customization of the graft to optimize the overlap of the superior end of the graft with healthy tissue in the aorta, without jailing the renal arteries. This may be desirable in patients having a first renal artery which opens into the aorta at a first level evaluated along the direction of blood flow, and a second renal artery opening into the aorta at a second, different level which may be lower or farther downstream than the first level. A first iliac D-graft may be deployed such that the superior end resides inferiorly to the second level, and the graft is on the second level side of the cuff. The second iliac graft may be implanted with a superior end at a higher level such that it is just inferior to the first renal artery, and offset from the superior end of the first iliac graft by at least about 0.5 cm, at least about 1.0 cm, in some instances at least about 2.0 cm.
Referring now to
The present invention has been described and illustrated in connection with certain specific embodiments thereof. However, it will be understood by those skilled in the art that various changes in form and details may be made therein without departing from the scope and spirit of the invention. For all of the embodiments described above, the various elements and variables may be interchanged, and the steps of the method may be interchanged, without departing from the present invention.
This application is a continuation-in-part of U.S. patent application Ser. No. 12/466,044 filed May 14, 2009 which application claims the Paris Convention Priority benefit of U.S. Provisional 61/053,378 filed May 15, 2008.
Number | Date | Country | |
---|---|---|---|
61053378 | May 2008 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12466044 | May 2009 | US |
Child | 12628131 | US |